World Drug Sales In January-April

9 July 1997

Sales of pharmaceutical products in the world's 10 leading marketsincreased 6% during the first four months of 1997 to a total of $54.5 billion, according to new data published by IMS International.

Fastest market growth during the period was reported for North America, with sales in the USA and Canada rising 11% and 10% respectively.

The seven leading European markets showed combined growth of 4%, up from 3% during the first quarter, with the greatest advance reported for Spain, with turnover rising 9%, according to IMS. Sales in Italy and the UK increased 6% in the period, while France advanced 5%. Growth in Germany was flat, after the decline of 1% reported for the first quarter of the year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight